American Portfolios Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
CS
American Portfolios Advisors's NVAX Position: Q3 2022 in Review
American Portfolios Advisors increased its Novavax (NVAX) stake by 30% in Q3 2022, buying an estimated $8.49K and bringing the position to 848 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2314.
American Portfolios Advisors first reported a position in NVAX in Q4 2017 and has held it in 20 quarters since. The position peaked at $370K in Q4 2020. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.
- American Portfolios Advisors held 848 shares of Novavax worth $15.4K as of Q3 2022.
- American Portfolios Advisors bought 196 Novavax shares in Q3 2022, an estimated $8.49K.
- Novavax made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2314 holding.
- American Portfolios Advisors first reported a position in Novavax in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Novavax position peaked at $370K in Q4 2020.
- 254 funds tracked by Wall St. Rank held Novavax as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.